vimarsana.com

Page 319 - Initiated Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

OncoCyte (NASDAQ:OCX) Coverage Initiated at StockNews com

Equities researchers at StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the stock. A number of other equities analysts have also weighed in on OCX. Piper Sandler decreased their price target on shares […]

S&W Seed (NASDAQ:SANW) Coverage Initiated at StockNews com

StockNews.com began coverage on shares of S&W Seed (NASDAQ:SANW – Free Report) in a research note published on Saturday morning. The firm issued a sell rating on the stock. Separately, TheStreet downgraded S&W Seed from a c- rating to a d+ rating in a research note on Friday, October 27th. Read Our Latest Stock Analysis […]

Pulmatrix (NASDAQ:PULM) Coverage Initiated by Analysts at StockNews com

StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Pulmatrix Stock Up 1.8 % PULM opened at $1.78 on Friday. Pulmatrix has a 52-week low of $1.64 and a 52-week high of […]

Smart Powerr (NASDAQ:CREG) Research Coverage Started at StockNews com

StockNews.com assumed coverage on shares of Smart Powerr (NASDAQ:CREG – Free Report) in a report released on Sunday. The brokerage issued a sell rating on the business services provider’s stock. Smart Powerr Trading Up 2.3 % NASDAQ CREG opened at $1.32 on Friday. The company has a market cap of $10.51 million, a PE ratio […]

ZoomInfo Technologies (NASDAQ:ZI) Coverage Initiated by Analysts at Jefferies Financial Group

Investment analysts at Jefferies Financial Group assumed coverage on shares of ZoomInfo Technologies (NASDAQ:ZI – Get Free Report) in a research note issued on Wednesday, Briefing.com reports. The brokerage set a “buy” rating and a $20.00 price target on the stock. Jefferies Financial Group’s price objective suggests a potential upside of 30.21% from the stock’s […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.